4
Changes in Ownership
Harmony Biosciences Holdings, Inc. Filed Acc 0001415889-24-025826
CHIEF COMMERCIAL OFFICER sold 21,496 shares at $40.47 ($870,018)
- CHIEF COMMERCIAL OFFICER acquired 21,496 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dierks Jeffrey CHIEF COMMERCIAL OFFICER | 2024-10-29 | Option exercise 10b5-1 | +21,496 | $24.00 | $515,904 | 21,496 | D |
| Dierks Jeffrey CHIEF COMMERCIAL OFFICER | 2024-10-29 | Sale 10b5-1 | −21,496 | $40.47 | $870,018 | 0 | D |
| Derivatives | |||||||
| Dierks Jeffrey CHIEF COMMERCIAL OFFICER | 2024-10-29 | Option exercise · Stock Option 10b5-1 | −21,496 | 28,972 | D | ||
| Open-market sales · 21,496 sh · avg $40.47 · $870,018 | |||||||
Loading xslF345X05/form4-10312024_081034.xml…